Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-011259
Filing Date
2012-11-08
Accepted
2012-11-08 14:52:13
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q hxbm_10q-093012.htm 10-Q 793780
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 17613
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 18180
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6952
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6952
  Complete submission text file 0001437749-12-011259.txt   5331343

Data Files

Seq Description Document Type Size
6 hxbm-20120930.xml EX-101.INS 894851
7 hxbm-20120930.xsd EX-101.SCH 45067
8 hxbm-20120930_cal.xml EX-101.CAL 37316
9 hxbm-20120930_def.xml EX-101.DEF 240431
10 hxbm-20120930_lab.xml EX-101.LAB 293809
11 hxbm-20120930_pre.xml EX-101.PRE 244913
Mailing Address 22121 17TH AVE SE SUITE 112 BOTHELL WA 98021
Business Address 22121 17TH AVE SE SUITE 112 BOTHELL WA 98021 425 402 8400
HELIX BIOMEDIX INC (Filer) CIK: 0000831749 (see all company filings)

EIN.: 912099117 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-20897 | Film No.: 121189713
SIC: 2834 Pharmaceutical Preparations